Back to Results
Nicole F Ruopp, MD
Accepting New Patients
Pulmonary and Critical Care Physician, Assistant Professor of Medicine
Department + Services
Medicine, Pulmonary, Critical Care and Sleep Medicine
Clinical Focus Areas
Pulmonary Hypertension, Cardiac Intensive Care, Mechanical Circulatory Support
Research Focus Areas
Decompensated Pulmonary Hypertension, Mechanical Circulatory Support
Seeing Patients In
|Training + Education
University of Arkansas for Medical Sciences; Duke University/Duke University Medical Center (Internal Medicine Residency), Boston University/Boston Medical Center (Pulmonary and Critical Care Fellowship), Harvard Medical School/Brigham and Women's Hospital (Advanced Fellowship in Pulmonary Hypertension)
||Internal Medicine, Pulmonary Medicine
||View Accepted Insurances at Tufts MC + Tufts Children's Hospital
Tufts Medical Center
260 Tremont Street
Boston, MA 02111
Phone #: 617-636-6377
Fax #: 617-636-1649
Ruopp NF, Farber HW. Gaps and controversies of new treatment recommendations in recent pulmonary hypertension guidelines: What we know and what we don’t. Advances in Pulmonary Hypertension 2017;16(1):20-25.
Parikh K, Dahhan T, Nicholl L, Ruopp N, Pomann GM, Fortin T, Tapson V, Rajagopal S. Clinical Features and Outcomes of Patients with Sarcoidosis-associated Pulmonary Hypertension. Scientific Reports 2019;9:4061.
Ruopp NF, Schoenberg NC, Farber HW. Swan-Ganz and Pericardial Pressure-Guided Pericardiocentesis in Pulmonary Arterial Hypertension-Associated Cardiac Tamponade. Annals of the American Thoracic Society 2019;16(9):1189-1191.
Ruopp NF, Farber HW. The new World Symposium on Pulmonary Hypertension guidelines: Should twenty-one be the new twenty-five? Circulation 2019;140:1134-1136.
Ruopp NF, Maron BA. Pulmonary Hypertension in the modern era: the intersection of genotype and phenotype. Journal of Heart and Lung Transplant 2020 Feb;39(2):113-114. Epub 2019 Nov 9.
Schoenberg NC, Ruopp NF, Farber HW. A 46-Year Old Man on Hemodialysis with Dyspnea and an Abnormal Echocardiogram. Annals of the American Thoracic Society 2019;16:1577-1581.
Ruopp NF, Farber HW. The Elephant Man Meets Pulmonary Hypertension: A Cautionary Tale. American Journal of Respiratory and Critical Care Medicine 2020: 15;202(6):789-791.
Shioleno AM, Ruopp NF. Group 3 Pulmonary Hypertension: A Review of Diagnostics and Clinical Trials. Clinics in Chest Medicine 2021: Mar;42(1):59-70.
Cramer-Bour C, Ruhl AP, Nouraie SM, Emeh RO, Ruopp NF, Thein SL, Weir NA, Klings ES. Long Term Tolerability of Phosphodiesterase-5 Inhibitors in Sickle Cell Disease. Eur J Haematol. 2021 Jul;107(1):54-62. Epub 2021 Apr 15.
Menon AM, Ruopp NF, Parakh A, Cockrill B, Waxman AB. A 65-year-old woman with a repaired atrial septal defect and pulmonary hypertension with worsening dyspnea. Annals of the American Thoracic Society. 2021 Jun;18(6):1052-1058.
Ruopp NF, Waxman AB. (2019). ‘Group 1 Clinical Features and Treatment’ in Peacock A (ed.) The Encyclopedia of Respiratory Medicine, 2nd Edition, in press.